HAMP and hemochromatosis type 1: The higher occurrence of cardiovascular death and non-ischemic cardiovascular abnormalities in hemochromatosis patients as well as the role of hepcidin in Fe retention by macrophages and their consequent transformation into foam cells is currently under investigation.